Posted Apr. 1, 2014 at 5:56 a.m.

Premium Lock Biogen receives FDA approval for hemophilia drug

Published: 2014-04-01 05:56:20
Updated: 2014-04-01 05:56:20

Biogen Idec Biogen

The sufferers of hemophilia B will soon have a new treatment option from Biogen. The drug company, which operates a huge manufacturing facility in RTP, on Friday received FDA approval for Alprolix and now will enter the $1 billion a year hemophilia market....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Frank Vinluan
Life science
Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Scroll